Showing results (2061-2070 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|January 22, 2005
Changes in the costs of treating mental health disorders: an overview of recent research findingsErnst R BerndtPharmacoeconomics|June 18, 2005
Incorporation of uncertainty in health economic modelling studiesAnthony O'Hagan, Christopher McCabe, Ron Akehurst, et al.Pharmacoeconomics|June 18, 2005
Health utilities in Alzheimer's disease and implications for cost-effectiveness analysisPeter J NeumannPharmacoeconomics|June 18, 2005
Bipolar disorder and health-related quality of life : review of burden of disease and clinical trialsDennis A Revicki, Louis S Matza, Emuella Flood, et al.Pharmacoeconomics|March 8, 2005
The case for stratified cost-effectiveness analysis by baseline health-related QOL: theory and sensitivity analysisJoseph SchaafsmaPharmacoeconomics|March 8, 2005
Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart diseaseJoel W Hay, Kimberly L SterlingPharmacoeconomics|February 8, 2005
Pharmacoeconomic impact of non-compliance with statinsAndrew M Peterson, William F McGhanPharmacoeconomics|January 27, 2005
Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemiaJohn R Cook, Don Yin, Evo Alemao, et al.Pharmacoeconomics|May 18, 2005
Valuing patient and caregiver time: a review of the literatureJennifer E Tranmer, Denise N Guerriere, Wendy J Ungar, et al.Pharmacoeconomics|May 18, 2005
Economic considerations in the prescribing of third-generation antidepressantsStuart Montgomery, John J Doyle, Lee Stern, et al.Pageof 336